Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma

This study has been completed.
Sponsor:
Collaborators:
National Heart and Lung Institute
Imperial College London
British Lung Foundation
Information provided by (Responsible Party):
Royal Brompton & Harefield NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT00262340
First received: December 5, 2005
Last updated: October 28, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)